Ustekinumab, sold under the brand name Stelara among others, is a monoclonal antibody medication used for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis, [31] targeting both IL-12 and IL-23. [32]

Dec 20, 2024 · Ustekinumab is a biologic drug that was originally approved to treat moderate to severe plaque psoriasis. Ustekinumab is now also approved to be used for psoriatic arthritis, Crohn’s disease and ulcerative colitis.

Learn about STELARA® (ustekinumab), a biologic used for Crohn’s disease, ulcerative colitis, plaque psoriasis & psoriatic arthritis treatment. See Full Prescribing & Safety Info.

Dec 20, 2024 · Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis. Stelara is an interleukin inhibitor that blocks IL-12 and IL-23.

Jul 19, 2021 · Ustekinumab is a human monoclonal antibody typically used to treat moderate to severe plaque psoriasis, psoriatic arthritis, moderate to severe Crohn disease, or moderate to severe ulcerative colitis (inflammatory bowel disease).

Stelara (ustekinumab) is commonly used to treat the following inflammatory conditions. Moderate to severe plaque psoriasis, which is a skin condition; Psoriatic arthritis, which is a type of...

Stelara® is a brand of ustekinumab that treats plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis. This medication treats symptoms of these conditions and it isn’t a cure. A healthcare provider usually gives you this injection in a hospital or clinic setting.

Oct 1, 2024 · Ustekinumab injection is used to treat moderate to severe plaque psoriasis in patients who may benefit from receiving phototherapy (ultraviolet light treatment) or other treatments. This medicine may be used alone or in combination with methotrexate to treat active psoriatic arthritis.

Ustekinumab (Stelara) is a medication prescribed for the treatment of moderate to severe plaque psoriasis in adult patients over the age of 18 years. Candidates for ustekinumab (Stelara) are patients able to tolerate phototherapy or medications that are absorbed into the blood stream.

Description for Steqeyma. Ustekinumab-stba, a human IgG1κ monoclonal antibody, is a human interleukin-12 and -23 antagonist.Using DNA recombinant technology, ustekinumab-stba is produced in a Chinese Hamster Ovary (CHO) cell line. The manufacturing process contains steps for the clearance of viruses.Ustekinumab-stba is comprised of 1326 amino acids and has an …